These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31190658)

  • 41. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
    Jacobsen FM
    J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Valproate use in children and adolescents with bipolar disorder.
    Azorin JM; Findling RL
    CNS Drugs; 2007; 21(12):1019-33. PubMed ID: 18020481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term use of valproate in primary psychiatric disorders.
    Hayes SG
    J Clin Psychiatry; 1989 Mar; 50 Suppl():35-9. PubMed ID: 2494158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Valproate for acute mood episodes in bipolar disorder.
    Macritchie K; Geddes JR; Scott J; Haslam D; de Lima M; Goodwin G
    Cochrane Database Syst Rev; 2003; (1):CD004052. PubMed ID: 12535506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of Perinatal Women Attending a Mother and Baby Unit Taking Sodium Valproate or Lithium with a Diagnosis of Bipolar Affective Disorder.
    Lebedevs T; Gan M; Teoh SWK; Brown P
    Psychiatr Q; 2020 Sep; 91(3):695-701. PubMed ID: 32157548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
    Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
    CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment decisions in women of childbearing age on valproate.
    Harris L; Lowes O; Angus-Leppan H
    Acta Neurol Scand; 2020 Apr; 141(4):287-293. PubMed ID: 31883101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Valproate preparations for agitation in dementia.
    Lonergan E; Luxenberg J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries.
    Hurault-Delarue C; Morris JK; Charlton R; Gini R; Loane M; Pierini A; Puccini A; Neville A; Snowball J; Damase-Michel C;
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1510-1518. PubMed ID: 31517430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
    Christensen J; Grønborg TK; Sørensen MJ; Schendel D; Parner ET; Pedersen LH; Vestergaard M
    JAMA; 2013 Apr; 309(16):1696-703. PubMed ID: 23613074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Valproate in Pregnancy: Recent Research and Regulatory Responses.
    Andrade C
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29873961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unexpected Cataract Formation Following Valproate Treatment: A Case Report.
    Sinha N; Patil PS; Ananta A; Suresh SB; Unni N
    Cureus; 2024 Jun; 16(6):e63093. PubMed ID: 39055475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The emerging story of Sodium Valproate in British newspapers- A qualitative analysis of newspaper reporting.
    Siriwardena S; McAllister N; Islam S; Craig J; Kinney M
    Seizure; 2022 Oct; 101():127-133. PubMed ID: 35973301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study.
    Musetti L; Tundo A; Benedetti A; Massimetti G; Cambiali E; Pergentini I; Del Grande C; Dell'Osso L
    Hum Psychopharmacol; 2018 Nov; 33(6):e2676. PubMed ID: 30311959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Valproate: Not All Boxed Warnings Are Created Equal.
    Wartman C; VandenBerg A
    Ann Pharmacother; 2022 Dec; 56(12):1349-1355. PubMed ID: 35392666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Real-world prescribing trends of valproate in women with epilepsy in Korea.
    Han SH; Lee H; Shin JY; Moon HJ; Lee SY
    Epilepsy Behav; 2021 Feb; 115():107700. PubMed ID: 33421853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum valproate levels in 6 breastfeeding mother-infant pairs.
    Piontek CM; Baab S; Peindl KS; Wisner KL
    J Clin Psychiatry; 2000 Mar; 61(3):170-2. PubMed ID: 10817100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valproate in acute mania: is our practice evidence based?
    Vasudev K; Mead A; Macritchie K; Young AH
    Int J Health Care Qual Assur; 2012; 25(1):41-52. PubMed ID: 22455007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. National compliance with UK wide guidelines for usage of valproate in women of childbearing potential.
    Eriksson SH; Tittensor P; Sisodiya SM
    Seizure; 2022 May; 98():8-12. PubMed ID: 35395505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.